NCT00270816View on ClinicalTrials.gov

Interferon ß-1b Treatment by Cyclical Administration

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

August 31, 2010

Study Completion Date

January 31, 2011

Conditions
Multiple Sclerosis
Interventions
DRUG

Interferon-ß-1b

250 micrograms (8 MIU) administered subcutaneously (sc) every other day with a discontinuance month every 2 months

DRUG

Interferon ß-1b

250 micrograms (8 MIU) administered subcutaneously (sc) every other day

Trial Locations (1)

00139

"Azienda Ospedaliera S. Andrea, II Facoltà di Medicina e Chirurgia, Università di Roma La Sapienza", Rome

All Listed Sponsors
collaborator

Italian Multiple Sclerosis Foundation

OTHER

lead

S. Andrea Hospital

OTHER

NCT00270816 - Interferon ß-1b Treatment by Cyclical Administration | Biotech Hunter | Biotech Hunter